XVI International AIDS Conference Toronto HIV Epidemiology Update based on Plenary Presentation C hris Beyrer MD, MPH Johns Hopkins Bloomberg.

Slides:



Advertisements
Similar presentations
State of the Art The Status and Trends of HIV/AIDS Epidemics
Advertisements

The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
School of Public Health and Community Medicine HIV prevalence, incidence and mortality in prison: A global overview Professor Kate Dolan and Babak Moazen.
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
The HIV/AIDS Epidemic © 2005 John B. Pryor Illinois State University.
The HIV/AIDS Epidemic © 2008 John B. Pryor Illinois State University.
25 Years of HIV – Africa and beyond Carol Ciesielski, MD
The Political Geography of AIDS
UNAIDS, Regional Support Team, Eastern and Southern Africa
The Most Probable Past, Present, and Future of the AIDS Pandemic JAMES (Jim) CHIN MD, MPH Clinical Professor of Epidemiology School of Public Health University.
HIV/AIDS epidemics among men who have sex with men (MSM) in Africa, Asia, Latin America and the Caribbean, and the CIS July 18th, 2008 Chris Beyrer MD.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Regional Overview of Progress on Universal Access in Asia-Pacific Steve Kraus, Regional Director UNAIDS Regional Support Team for Asia and the Pacific.
EG3244 Development Geographies The AIDS crisis Dr Mark Cresswell.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
Bell Ringer What conditions could lead to an atmosphere susceptible to genocide?
Total: 42 million Western Europe 570,000 North Africa & Middle East 550,000 Sub-Saharan Africa 29.4 million Eastern Europe & Central Asia 1.2 million South.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Key Affected Populations.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
OVERVIEW OF THE HIV/AIDS EPIDEMIC Marie Laga
Introduction About HIV/AIDS in Hangzhou Hangzhou Center For Disease Control And Prevention — by Zhao Gang — by Zhao Gang.
00002-E-1 – 1 December 2002 The AIDS Pandemic: an Update on the Numbers and Needs l What are the numbers for 2002? l What are the global and regional trends?
Washington D.C., USA, July 2012www.aids2012.org Sources of HIV Epidemiological Data for Monitoring and Estimating the burden of HIV Txema Calleja,
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Papua New Guinea Last updated: July 2015.
Ami R. Moore, PhD Department of Sociology University of North Texas 12/01/2011.
Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,
AIDS Epidemic Update December /06 e. AIDS Epidemic Update December /06 e TOTAL North America Eastern Europe & Central Asia Latin America.
PEPFAR Investment Strategy (8 years of PEPFAR) Data source : OGAC Budget Total PEPFAR Investment: $21,285,918,291 Saving Lives : Changing the.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Key Affected Populations.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Timor-Leste Last updated: December 2014.
HIV/AIDS Epidemics Among MSM In Developing Countries AMFAR: HIV Prevention among MSM August 17, 2006 Toronto Chris Beyrer MD, MPH The Center for Public.
HIV/AIDS epidemics among men who have sex with men (MSM) in Africa, Asia, Latin America and the Caribbean, and the CIS Full Enjoyment of Human Rights by.
AFRICA HIV/AIDS AIDS DATA SOURCE: UNAIDS 2007 REPORT WORLD HEALTH ORGANIZATION.
Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.
High-impact interventions. Number of people living with HIV who were not receiving antiretroviral therapy, 2014 and 2015 Source: UNAIDS estimates, 2014.
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
India Last updated: January 2016.
Ecdc.europa.eu Epidemiological Situation of HIV/AIDS in the EU and its Neighbouring Countries German Presidency Conference Responsibility & Partnership.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Mongolia Last updated: December 2014.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: June 2015.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
The PHRplus Project is funded by U.S. Agency for International Development and implemented by: Abt Associates Inc. and partners, Development Associates,
Africans and HIV in the UK: an epidemiological perspective May 2006 Valerie Delpech On behalf of the HIV Reporting Section with special thanks to Julia.
Global HIV Epidemiology Carey Farquhar, MD, MPH Grace John-Stewart MD, PhD Departments of Medicine, Epidemiology and Global Health.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: April 2016.
Number of people living with HIV on antiretroviral therapy, global, 2010–2015
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
1 Module 1: [Basic] Unit 1: [HIV Epidemics and Key Populations] Lesson 2: [Levels of HIV Epidemic in the World] “Community-Based HIV Surveillance” Online.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka Last updated: April 2016.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
HIV and AIDS Data Hub for Asia-Pacific Review in slides Thailand Last updated: January 2016.
Prevention Science Gaps and the HIV/AIDS Pandemic Quarraisha Abdool Karim, PhD Head: CAPRISA Women and AIDS Pogramme Associate Professor in Epidemiology,
Track C: Epidemiology, prevention and prevention research Quarraisha Abdool Karim (Chief Rapporteur) Team: Marian Swart, Ken Mayer, Cheryl Baxter, Ayesha.
Global Impact of HIV/AIDS Deborah Lewinsohn, M.D. Infectious Diseases, Pediatrics Vaccine and Gene Therapy Institute Oregon Health & Science University.
Singapore Last updated: November 2016.
Mongolia Last updated: April 2016.
Pakistan Last updated: July 2015.
Myanmar Last Update: September 2016.
Key Affected Populations
وضعیت HIV/AIDS در جهان ومنطقه مرکز مدیریت بیماری ها - اداره كنترل ایدز و بیماری های آمیزشی
People who inject drugs
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS Surveillance in Europe
Myanmar Last Update: November 2014.
Key Affected Populations
Presentation transcript:

XVI International AIDS Conference Toronto HIV Epidemiology Update based on Plenary Presentation C hris Beyrer MD, MPH Johns Hopkins Bloomberg School of Public Health

Global HIV epidemic, 1990 ‒ 2005 Number of people living with HIV % HIV prevalence, adult (15-49 ) % HIV prevalence, adult (15 ‒ 49) Number of people living with HIV (millions) Source: UNAIDS 2006 Bar indicates the range around the estimate 38.6 million living with HIV [33 to 46 million] 24.5 million in SS Africa [21.6 to 27.4 million]

IMPORTANCE OF PREVENTION (estimates 2005) 40.3 million people living with HIV/AIDS In 06/ million on ART 3.1 million AIDS related Deaths 4.9 million new HIV infections

Prevalence main determinant of incidence 40 million People living with HIV/AIDS 3.1 million AIDS related deaths 4.9 million New HIV infections

A global view of HIV infection, 2005 Source: UNAIDS 2006 Report on the Global AIDS Pandemic 1.5 million 200,000 in ‘05 IDU 7.6 million 830,000 in ‘05 Heterosexual MSM IDU 12.1 million 1.3 million in ‘05 Heterosexual

States with at least one site with HIV prevalence > 20% in IDU in 2006 Belarus Estonia Kazakhstan Russia Ukraine Serbia & Montenegro Iran Nepal Indonesia Libya Mauritius Kenya, Tanzania, Ghana, Nigeria** Burma China India Malaysia Thailand Vietnam Italy Netherlands Portugal Spain Argentina Brazil Uruguay Canada Puerto Rico USA **African States with at least one published report of IDU risks Emergent Epidemics Adapted from : Aceijas, et al, AIDS : Established Epidemics

Individual Level Determinants for Parenteral HIV Infection Needle sharing Higher frequency of injection Cocaine injection Lack of opioid analogue therapy MSM-IDU history Injection use while incarcerated

Reported HIV cases in the Russian Federation and Ukraine, 1987– Reported HIV cases in the Russian Federation Reported HIV cases in Ukraine Russian Federation Newly reported cases Cumulative (previous years) Ukraine Newly reported cases Cumulative Adapted from : Russian Federal AIDS Centre; Ukranian AIDS Centre and Ministry of Health of Ukraine, UNAIDS 2006 Report on the Global AIDS Pandemic

What are the Structural Drivers of Spread Across Eurasia? Driver # 1 Geographic proximity to overland drug trafficking routes Driver # 2 Limited use of HIV prevention measures with demonstrated efficacy for IDU transmission Driver # 3 Punitive and legalistic approaches to IDUs

Opiate seizures in Asia in 2004 Source : UNODC World Drug Report 2006

Sources: IDU Estimates: UNODC HIV/AIDS unit, September 2005; WHO/UNAIDS October Published in Harm Reduction Developments International Harm Reduction Development Program (IHRD) of the Open Society Institute UNAIDS recommends 60% coverage for effective HIV prevention among IDUs IDUs Reached by NSEP, Select FSU Countries, 2005

Structural limits on prevention & care for IDU US continues ban on federal funding for Needle Syringe Exchange Programs (NSEP) in US and globally Methadone Maintenance Therapy (MMT) remains illegal in many countries Ex: Russian Federation Across 50 developing countries, 34,000 IDU on ARV: 30,000 were in Brazil Source: Aceijas, et al, Addiction, 2006

Photo: Hans Jürgen Burkard

MSM Trends in High and Low Income Country Settings

Estimated Number of HIV/AIDS Diagnoses, by Transmission Category — 33 States, 2001–2004. * Statistically significant Source: Espinoza, CDC, 2005

Trends HIV among MSM mid ’90- now HAART introduced, resulting in dramatic improvement of survival of AIDS patients, as well as reduction in AIDS cases HIV/AIDS becomes a “chronic disease” and “less visible” Rise in “unsafe sex” and STI, including outbreaks of Syphylis and LGV

Sexual orientation of male syphilis cases registered in the sentinel network of clinicians, Belgium, Oct Jan 2003 From: IPH, Belgium

Possible explanations for increased risk behaviour HAART changed the face of the epidemic: less AIDS and less deaths Prevention fatigue: challenge of maintaining safe sex for an extended period Changing environment : internet as new way of recruiting partners Young MSM (<20y) sexually active earlier, and never exposed to AIDS as a killer disease

Source: Wade et al. 2005; Girault et al. 2004; van Grievsven et al. 2005; Action for AIDS Singapore, 2006, Go et al. 2004; Pando et al. 2006; UNAIDS, 2006; Caceres et al, 2005, Strathdee, et al, CENSIDA, CA State Office of AIDS; Patterson et al, IAS, 2006; Strathdee et al, pers. comm; Viani et al, 2006 HIV prevalence among MSM in low prevalence settings

HIV prevalence among MSM, Bangkok, Thailand Age (years) ≤ ≥29 N = 194/1,121; 113/399 Overall Source: Van Griensven, et al, MMWR HIV Prevalence (%) p-values all < 0.05

MSM structural risk contexts Criminalization and stigma limit MSM access to HIV prevention, treatment and care MSM understudied in emerging contexts: MSM not included in national HIV surveillance in Thailand, Vietnam, Senegal Only one African study (Wade, et al) of MSM risk and HIV rates Fewer than 1 in 10 MSM worldwide have access to necessary prevention services Sources: UNAIDS; USAID, 2004; Wade 2005; Go 2006 personal communication; HRW; UNAIDS 2006

HIV prevalence in adults in Africa Source : UNAIDS, 2006

RegionCountry Population- based survey prevalence (%) (year) Adjusted 2003 HIV prevalence (%) in current report 2005 HIV prevalence (%) in current report Trend in prevalence SOUTH Botswana25.2 (2004) Stable Lesotho23.5 (2004) Stable South Africa16.2 (2005) Increasing EAST Burundi 3.6 (2002)3.3 Decline in capital city Rwanda 3.0 (2005)3.83.1Decline in urban areas Tanzania 7.0 (2004)6.66.5Stable Uganda 7.1 (2004-5)6.86.7Stable WEST Burkina Faso 1.8 (2003)2.12.0Decline in urban areas Cameroon 5.5 (2004)5.55.4Stable Ghana 2.2 (2003)2.3 Stable Guinea 1.5 (2005)1.61.5Stable Senegal 0.7 (2005)0.9 Stable Sierra Leone 1.5 (2005)1.6 Stable HORN Ethiopia 1.6 (2005)( )( )Decline in urban areas Adult HIV prevalence in Sub-Saharan Africa, 2003 and Source: UNAIDS 2006 Report on the Global AIDS Epidemic

HIV prevalence by age and gender South Africa – 1920 – 2425 – 29 Age group (years) HIV Positive (%) Males Females Source: South African National HIV Prevalence, Incidence, Behavior and Communication Survey, 2005

Ecological Model for HIV Risk in Southern Africa Individual Risks for HIV Infection Widening Risk Contexts for HIV Infection Beyrer & Baral, 2006 Condom Usage, Circumcision, HSV-2/GUD, Viral Load, Acute Infection, Age of Coital Debut, Marriage, ARV Status